InfuSystem Holdings, Inc(INFU)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

InfuSystem Holdings, Inc (INFU) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INFU at 58.2/100 on a 32-signal composite quality model, placing it at rank #1,038 of 2,962 stocks — the top half of the AI-ranked universe. INFU scores in the top quartile across earnings quality (88.9), balance sheet strength (82.4), institutional flow (81.7). Areas of concern include revenue scale (19.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 32.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), InfuSystem Holdings, Inc reports quarterly revenue of $36.9M, net income of $3.2M, an operating margin of 11.2%. Top institutional holders of INFU by reported 13-F value include BlackRock, Minerva Advisors, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, based on the most recent SEC filings. INFU trades on the NYSE exchange and files with the SEC under CIK 1337013. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INFU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InfuSystem Holdings, Inc directly from SEC EDGAR.